Conditions & Recovery · Cancer Health — Science · June 4, 2026

Targeted Drug Outperforms Chemotherapy for Patients with Hard-to-Treat Lung Cancer

Sunvozertinib extended survival and showed greater antitumor activity than standard chemotherapy.

Originally published by Cancer Health — Science. We curate and add context; they did the reporting.

Related learning